Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates-Reference-Cited by-同舟云学术

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates

Published:2022-04 Issue:10 Volume:82 Page:1040-1050
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Sorce Gabriele¹²^ORCID,Flammia Rocco Simone²³,Hoeh Benedikt²⁴^ORCID,Chierigo Francesco²⁵,Hohenhorst Lukas²⁶,Panunzio Andrea²⁷,Stabile Armando¹,Gandaglia Giorgio¹,Tian Zhe²,Tilki Derya⁶⁸⁹^ORCID,Terrone Carlo⁵,Gallucci Michele³,Chun Felix K. H.⁴,Antonelli Alessandro⁷,Saad Fred²,Shariat Shahrokh F.¹⁰¹¹¹²¹³¹⁴,Montorsi Francesco¹,Briganti Alberto¹,Karakiewicz Pierre I.²

Affiliation:

1. Department of Urology, Division of Experimental Oncology URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute Milan Italy

2. Division of Urology, Cancer Prognostics and Health Outcomes Unit University of Montréal Health Center Montréal Québec Canada

3. Department of Maternal‐Child and Urological Sciences, Policlinico Umberto I Hospital Sapienza University of Rome Rome Italy

4. Department of Urology University Hospital Frankfurt Frankfurt am Main Germany

5. Department of Surgical and Diagnostic Integrated Sciences (DISC) University of Genova Genova Italy

6. Department of Urology Martini‐Klinik Prostate Cancer Center, University Hospital Hamburg‐Eppendorf Hamburg Germany

7. Department of Urology University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona Verona Italy

8. Department of Urology University Hospital Hamburg‐Eppendorf Hamburg Germany

9. Department of Urology Koc University Hospital Instanbul Turkey

10. Departments of Urology Weill Cornell Medical College New York New York USA

11. Department of Urology University of Texas Southwestern Dallas Texas USA

12. Department of Urology, Second Faculty of Medicine Charles University Praga Czech Republic

13. Department of Urology, Institute for Urology and Reproductive Health I.M. Sechenov First Moscow State Medical University Moscow Russia

14. Division of Urology, Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24349

Reference29 articles.

1. A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy

2. Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registries

3. Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database

4. The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease

5. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b;International braz j urol;2024-08

2. Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate Cancer;European Urology Oncology;2024-07

3. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology;World Journal of Urology;2024-04-22

4. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?;International Urology and Nephrology;2024-03-30

5. Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models;European Radiology;2024-03-20